Sector
PharmaceuticalsOpen
₹50.16Prev. Close
₹51.18Turnover(Lac.)
₹0.35Day's High
₹50.16Day's Low
₹50.1652 Week's High
₹88.752 Week's Low
₹40.2Book Value
₹25.22Face Value
₹10Mkt Cap (₹ Cr.)
22.93P/E
46.02EPS
1.09Divi. Yield
07 May 2025
12:00 AM
Board Meeting
Agenda : Audited Result
8 Aug 2024
12:00 AM
AGM
Announcement Date: 08 Aug, 2024
| Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
Equity Capital | 2.52 | 2.52 | 3.55 | 3.55 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 6.43 | 5.62 | 4.14 | 3.75 |
Net Worth | 8.95 | 8.14 | 7.69 | 7.3 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Revenue | 6.11 | 7.53 | 7.95 | 8.04 |
yoy growth (%) | -18.88 | -5.29 | -1.1 | -0.59 |
Raw materials | -2.18 | -2.74 | -2.7 | -2.94 |
As % of sales | 35.72 | 36.4 | 33.96 | 36.58 |
Employee costs | -2.5 | -3.52 | -3.39 | -3.13 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Profit before tax | 0.24 | 0.17 | 0.15 | 0.11 |
Depreciation | -0.19 | -0.19 | -0.22 | -0.26 |
Tax paid | -0.03 | -0.04 | 0.07 | 0.02 |
Working capital | 1.08 | 0.76 | -0.11 | -0.08 |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | -18.88 | -5.29 | -1.1 | -0.59 |
Op profit growth | 9.63 | -15.59 | -12.37 | -9.23 |
EBIT growth | 36.58 | 3.28 | -0.36 | -11.69 |
Net profit growth | 59.12 | -43.44 | 63.45 | 49.18 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,647.35 | 92.29 | 3,95,254.45 | 2,000.46 | 0.97 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,493.2 | 78.03 | 1,72,374.06 | 667 | 0.46 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,483.15 | 24.33 | 1,19,795.19 | 1,485.4 | 1.08 | 4,254.47 | 397.41 |
Dr Reddys Laboratories Ltd DRREDDY | 1,326.4 | 20.69 | 1,10,689.83 | 1,200.7 | 0.6 | 5,546.3 | 345.79 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,167.95 | 56.27 | 1,07,213.01 | 474 | 1.01 | 2,385 | 224.33 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Director & Company Secretary
L S Mani
Whole-time Director
N K Menon
Independent Director
Bhavik Ashokkumar Shah
Independent Director
Baptist Benard Dias
Additional Director
Swapnil Jayesh Madiyar
A-101 Pratik Industrial Estate,
Mulund Goregaon Link Road,
Maharashtra - 400078
Tel: 91-022-25668002/8003
Website: http://www.colinz.com
Email: colinz@hathway.com; cllfindoc@yahoo.com
Office No 56-2,
Pinnacle Busine.Park, Mahakali Caves Road,
Mumbai - 400093
Tel: 91-22-62638200
Website: www.bigshareonline.com
Email: investor@bigshareonline.com
Summary
Colinz Laboratories Limited, was incorporated as a Private Limited Company in 1986. The Company got converted into Public Limited Company in 1995, which however started their manufacturing and marketi...
Read More
Reports by Colinz Laboratories Ltd
What is the Colinz Laboratories Ltd share price today?
What is the Market Cap of Colinz Laboratories Ltd?
What is the PE and PB ratio of Colinz Laboratories Ltd?
What is the 52 Week High and Low of Colinz Laboratories Ltd?
What is the CAGR of Colinz Laboratories Ltd?
What is the shareholding pattern of Colinz Laboratories Ltd?
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.